内分泌代謝高血圧研究部
発表論文
2019年
- Funamoto M, Shimizu K, Sunagawa Y, Katanasaka Y, Miyazaki Y, Kakeya H, Yamakage H, Satoh-Asahara N, Wada H, Hasegawa K, Morimoto T. Effects of highly absorbable curcumin in patients with impaired glucose tolerance and non-Insulin dependent diabetes mellitus. J Diabetes Res. 2019: 8208237, eCollection, 2019 (IF: 4.011, CI: 11) 査読付
- Funamoto M, Shimizu K, Sunagawa Y, Katanasaka Y, Miyazaki Y, Komiyama, M, Yamakage H, Satoh-Asahara N, Takahashi Y, Wada H, Hasegawa K, Morimoto T. Serum cystatin C, a sensitive marker of renal function and cardiovascular disease, decrease after smoking cessation. Circ Rep. 1: 623-627, 2019 (IF: 未掲載, CI: 未掲載) 査読付
- Miyamoto J, Ohue-Kitanoa R, Mukouyama H, Nishida A, Watanabe K, Igarashi M, Irie J, Tsujimoto G, Satoh-Asahara N, Itoh H, Kimura I. Ketone body receptor GPR43 regulates lipid metabolism under ketogenic conditions. Proc Natl Acad Sci U S A. 116: 23813-23821, 2019 (IF: 11.205, CI: 29) 査読付
- Kaneko H, Umakoshi H, Ishihara Y, Sugawa T, Nanba K, Tsuiki M, Kusakabe T, Satoh-Asahara N, Yasoda A, Tagami T. Seated saline infusion test in predicting subtype diagnosis of primary aldosteronism. Clin Endocrinol (Oxf). 91: 737-742 (IF: 3.478, CI: 6) 査読付
- Fukuda M, Fukuda S, Ando J, Yamamoto K, Yonemoto N, Suzuki T, Niwa Y, Inoue T, Satoh-Asahara N, Hasegawa K, Shimatsu A, Tsukahara T. Disruption of P2X4 purinoceptor suppresses the inflammation associated with cerebral aneurysm formation. J Neurosurg. 134: 102-114, 2019 (IF: 5.115, CI: 1) 査読付
- Inoue T, Yamakage H, Tanaka M, Kusakabe T, Shimatsu A, Satoh-Asahara N. Oxytocin suppresses inflammatory responses induced by lipopolysaccharide through inhibition of the eIF-2-ATF4 pathway in mouse microglia. Cells. 8: 527, 2019 (IF: 6.600, CI: 24) 査読付
- Inoue T, Saito S, Tanaka M, Yamakage H, Kusakabe T, Shimatsu A, Ihara M, Satoh-Asahara N. Pleiotropic neuroprotective effects of taxifolin in cerebral amyloid angiopathy. Proc Natl Acad Sci U S A. 116: 11031-11038, 2019 (IF: 11.205, CI: 27) 査読付
- Tanaka M, Yamakage H, Masuda S, Inoue T, Ohue-Kitano R, Araki R, Matoba Y, Saito M, Nagaoka T, Yonezawa K, Tanaka T, Suzuki M, Sawamura M, Nishimura M, Odori S, Wada H, Kotani K, Kusakabe T, Shimatsu A, Hasegawa K, Satoh-Asahara N. Serum soluble TREM2 is a potential novel biomarker of cognitive impairment in Japanese non-obese patients with diabetes. Diabetes Metab. 45: 86-89, 2019 (IF: 6.041, CI: 12) 査読付
- Ohara T, Hata J, Tanaka M, Honda T, Yamakage H, Yoshida D, Inoue T, Hirakawa Y, Kusakabe T, Shibata M, Teraoka T, Kitazono T, Kanba S, Satoh-Asahara N, Ninomiya T. Serum soluble TREM2 as a biomarker for incident dementia: the Hisayama study. Ann Neurol. 85: 47-58, 2019 (IF: 10.422, CI: 23) 査読付
- Tagami T, Hiroshima-Hamanaka K, Umakoshi H, Tsuiki-Naruse M, Kusakabe T, Satoh-Asahara N, Shimatsu A, Moriyama K. Experimental reproduction of dynamic fluctuation of TSH receptor-binding antibodies between stimulation and inhibition. J Endocr Soc. 3: 2361-2373, 2019 (IF: none, CI: 0) 査読付